Ads
related to: monoclonal antibody
Search results
Once-Promising Drug for Idiopathic Pulmonary Fibrosis Fails in Phase III Trial
MedPage Today· 1 day agoThe fully human monoclonal antibody pamrevlumab failed to improve lung function among patients with idiopathic pulmonary fibrosis (IPF) in the randomized ...
Mirikizumab Shows Promise for Moderate to Severe Crohn's
Medscape· 1 day agoAlready approved for ulcerative colitis, the monoclonal antibody mirikizumab met study endpoints for...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 2 hours agoAustin, TX, USA, May 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-Small-Cell Lung Cancer Drug Market Size, Trends and Insights By Cancer Type (Non-Small Cell Lung Cancer, Metastatic Lung
Duoning Collaborates with Bioelectronica to Commercialize a Single-Cell Sorting System for Antibody...
FOX 23 News Albany· 21 hours agoDuoning Biotechnology Group ("Duoning"), a leading one-stop bioprocess provider in China, today...
ADCs for Breast Cancer: Clear Benefits, Manageable Risks
Medscape· 4 hours agoADCs are rapidly changing the treatment landscape for patients with metastatic breast cancer, with the agents demonstrating improved efficacy and manageable risks.
Brokers Issue Forecasts for Rezolute, Inc.’s FY2024 Earnings (NASDAQ:RZLT)
ETF DAILY NEWS· 7 hours agoRezolute, Inc. (NASDAQ:RZLT – Free Report) – Equities research analysts at HC Wainwright lowered their FY2024 earnings per share estimates for shares of Rezolute in a research note issued to ...
Q3 2024 EPS Estimates for Equillium, Inc. Boosted by HC Wainwright (NASDAQ:EQ)
ETF DAILY NEWS· 7 hours agoEquillium, Inc. (NASDAQ:EQ – Free Report) – Investment analysts at HC Wainwright boosted their Q3 2024 earnings per share estimates for Equillium in a research report issued to clients and investors ...
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 7 days agoSanofi plans to invest €1bn in Vitry-sur-Seine to construct a new unit in a bid to double the ...
Bank of America Predicts up to ~200% Surge for These 2 ‘Strong Buy’ Stocks
TipRanks via Yahoo Finance· 2 days agoNew indicators of a cooling economy eased inflation concerns, driving the S&P 500 to record highs...
Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis -...
Benzinga· 6 days agoCelldex Therapeutics, Inc. CLDX today announced that the first patient has been dosed in the Company's Phase 2 subcutaneous study of barzolvolimab in prurigo nodularis (PN). Barzolvolimab is ...